Mycoplasma genitalium infection among HIV-positive women: prevalence, risk factors and association with vaginal shedding

This study examined the prevalence and factors associated with Mycoplasma genitalium (MG) infection among HIV-positive women and the association between MG and vaginal HIV-1 RNA shedding. HIV-positive women attending an outpatient clinic in New Orleans, Louisiana, USA, from 2002 to 2005 were examined for a battery of sexually transmitted infections (STIs) and underwent a behavioural survey. A selected subset had a measurement of vaginal shedding analysed. Of the 324 HIV-positive women, 32 (9.9%) were infected with MG. HIV-positive women with MG were more likely to be co-infected with Neisseria gonorrhoeae and Chlamydia trachomatis and to have had ≥1 male sexual partners in the last month. In the subset (n = 164), no differences were found in the presence of detectable vaginal HIV-1 RNA between women infected and not infected with MG (30.8% versus 34.8% shedding; P = 0.69). While MG was a common co-STI in this sample of HIV-positive women, it was not associated with vaginal HIV shedding.

[1]  L. Manhart Has the time come to systematically test for Mycoplasma genitalium? , 2009, Sexually transmitted diseases.

[2]  T. Quinn,et al.  Mycoplasma genitalium as a Contributor to the Multiple Etiologies of Cervicitis in Women Attending Sexually Transmitted Disease Clinics , 2009, Sexually transmitted diseases.

[3]  S. Kelsey,et al.  The demographic, sexual health and behavioural correlates of Mycoplasma genitalium infection among women with clinically suspected pelvic inflammatory disease , 2009, Sexually Transmitted Infections.

[4]  J. Ross,et al.  Mycoplasma genitalium in asymptomatic patients: implications for screening , 2009, Sexually Transmitted Infections.

[5]  H. Weiss,et al.  Association of Mycoplasma genitalium and HIV infection: a systematic review and meta-analysis , 2009, AIDS.

[6]  T. Farley,et al.  Trichomonas Vaginalis Treatment Reduces Vaginal HIV-1 Shedding , 2009, Sexually transmitted diseases.

[7]  L. Johnson,et al.  The Effect of Genital Tract Infections on HIV-1 Shedding in the Genital Tract: A Systematic Review and Meta-Analysis , 2008, Sexually transmitted diseases.

[8]  N. Reinton,et al.  Mycoplasma genitalium in women with lower genital tract inflammation , 2008, Sexually Transmitted Infections.

[9]  S. Birkelund,et al.  Mycoplasma genitalium, Chlamydia trachomatis, and tubal factor infertility--a prospective study. , 2008, Fertility and sterility.

[10]  M. Hobbs,et al.  Mycoplasma genitalium Detected by Transcription-Mediated Amplification Is Associated With Chlamydia trachomatis in Adolescent Women , 2008, Sexually transmitted diseases.

[11]  J. Baeten,et al.  High Mycoplasma genitalium organism burden is associated with shedding of HIV-1 DNA from the cervix. , 2008, The Journal of infectious diseases.

[12]  C. Haggerty Evidence for a role of Mycoplasma genitalium in pelvic inflammatory disease , 2008, Current opinion in infectious diseases.

[13]  R. Nguti,et al.  Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts , 2007, AIDS.

[14]  M. Beksinska,et al.  Microbicide Applicators: Understanding Design Preferences Among Women in the Dominican Republic and South Africa , 2007, Sexually transmitted diseases.

[15]  A. Meier,et al.  Mycoplasma genitalium Infection and Persistence in a Cohort of Female Sex Workers in Nairobi, Kenya , 2006, Sexually transmitted diseases.

[16]  M. Hudspeth,et al.  Comparison of Transcription-Mediated Amplification and PCR Assay Results for Various Genital Specimen Types for Detection of Mycoplasma genitalium , 2006, Journal of Clinical Microbiology.

[17]  Liang Ma,et al.  Sequence-Based Typing of Mycoplasma genitalium Reveals Sexual Transmission , 2006, Journal of Clinical Microbiology.

[18]  S. Kapiga,et al.  The epidemiology of HIV-1 infection in northern Tanzania: Results from a community-based study , 2006, AIDS care.

[19]  J. Jensen,et al.  Mycoplasma genitalium: prevalence, clinical significance, and transmission , 2005, Sexually Transmitted Infections.

[20]  R. Maserati,et al.  The effect of vaginal candidiasis on the shedding of human immunodeficiency virus in cervicovaginal secretions. , 2005, American journal of obstetrics and gynecology.

[21]  J. Jensen,et al.  Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection , 2005, Sexually Transmitted Infections.

[22]  M. Alary,et al.  Mycoplasma genitalium: an organism commonly associated with cervicitis among west African sex workers , 2005, Sexually Transmitted Infections.

[23]  J. Jensen Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseases , 2004, Journal of the European Academy of Dermatology and Venereology : JEADV.

[24]  K. Holmes,et al.  Mucopurulent cervicitis and Mycoplasma genitalium. , 2003, The Journal of infectious diseases.

[25]  T. Mroczkowski,et al.  Mycoplasma genitalium infections in asymptomatic men and men with urethritis attending a sexually transmitted diseases clinic in New Orleans. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  E. Frost,et al.  Mycoplasma genitalium is not associated with adverse outcomes of pregnancy in Guinea-Bissau , 2002, Sexually Transmitted Infections.

[27]  K. Holmes,et al.  Association between Mycoplasma genitalium and acute endometritis , 2002, The Lancet.

[28]  Mardge H. Cohen,et al.  Determinants of HIV-1 shedding in the genital tract of women , 2001, The Lancet.

[29]  R. McClelland,et al.  The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. , 2001, The Journal of infectious diseases.

[30]  R. McClelland,et al.  Treatment of cervicitis is associated with decreased cervical shedding of HIV-1 , 2001, AIDS.

[31]  A. Caliendo,et al.  Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA , 2000, AIDS.

[32]  P. Ghys,et al.  The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Côte d'Ivoire , 1997, AIDS.

[33]  B. Chohan,et al.  Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina , 1997, The Lancet.

[34]  裕 佐々木 Mycoplasmas stimulate replication of human immunodeficiency virus type 1 through selective activation of CD4[+] T lymphocytes , 1993 .